# Adding Nalbuphine for Control of Intrathecal Morphine Pruritus

> **NCT04589429** · PHASE2 · UNKNOWN · sponsor: **Minia University** · enrollment: 70 (estimated)

## Conditions studied

- Pruritus
- Pain, Postoperative
- Nausea, Postoperative
- Vomiting, Postoperative

## Interventions

- **DRUG:** Morphine 10 MG/ML
- **DRUG:** Nalbuphine Hydrochloride 10 MG/ML

## Key facts

- **NCT ID:** NCT04589429
- **Lead sponsor:** Minia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-15
- **Primary completion:** 2021-03
- **Final completion:** 2021-03
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2021-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04589429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04589429, "Adding Nalbuphine for Control of Intrathecal Morphine Pruritus". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04589429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*